Cargando…

A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]

Haritaki is praised as the best salutary drug which can be used in almost all ages of human life and is reputed for its Anulomana property. In Ayurveda, it has been mentioned that fruits of Haritaki when used in different forms give different type of actions. As the prime therapeutic utility of Hari...

Descripción completa

Detalles Bibliográficos
Autores principales: Jirankalgikar, Yogesh M., Ashok, B. K., Dwivedi, Rambabu R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665098/
https://www.ncbi.nlm.nih.gov/pubmed/23723658
http://dx.doi.org/10.4103/0974-8520.108866
_version_ 1782271207179026432
author Jirankalgikar, Yogesh M.
Ashok, B. K.
Dwivedi, Rambabu R.
author_facet Jirankalgikar, Yogesh M.
Ashok, B. K.
Dwivedi, Rambabu R.
author_sort Jirankalgikar, Yogesh M.
collection PubMed
description Haritaki is praised as the best salutary drug which can be used in almost all ages of human life and is reputed for its Anulomana property. In Ayurveda, it has been mentioned that fruits of Haritaki when used in different forms give different type of actions. As the prime therapeutic utility of Haritaki is Anulomana, in the present study, two dosage forms of Haritaki fruits namely Churna and Vati were evaluated for intestinal transit time to evaluate its effect in two different dosage forms. Mature fruits were collected, authenticated, and processed as per classics to get Churna and Vati. Test drugs were administered in the dose of 550 mg/kg and evaluation on intestinal transit time was carried out by adopting kaolin expulsion test in mice. The results show that both the dosage forms of Haritaki significantly shortened intestinal transit time and between them Churna form is found to be better.
format Online
Article
Text
id pubmed-3665098
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36650982013-05-30 A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.] Jirankalgikar, Yogesh M. Ashok, B. K. Dwivedi, Rambabu R. Ayu Short Communication Haritaki is praised as the best salutary drug which can be used in almost all ages of human life and is reputed for its Anulomana property. In Ayurveda, it has been mentioned that fruits of Haritaki when used in different forms give different type of actions. As the prime therapeutic utility of Haritaki is Anulomana, in the present study, two dosage forms of Haritaki fruits namely Churna and Vati were evaluated for intestinal transit time to evaluate its effect in two different dosage forms. Mature fruits were collected, authenticated, and processed as per classics to get Churna and Vati. Test drugs were administered in the dose of 550 mg/kg and evaluation on intestinal transit time was carried out by adopting kaolin expulsion test in mice. The results show that both the dosage forms of Haritaki significantly shortened intestinal transit time and between them Churna form is found to be better. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3665098/ /pubmed/23723658 http://dx.doi.org/10.4103/0974-8520.108866 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Jirankalgikar, Yogesh M.
Ashok, B. K.
Dwivedi, Rambabu R.
A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title_full A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title_fullStr A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title_full_unstemmed A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title_short A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.]
title_sort comparative evaluation of intestinal transit time of two dosage forms of haritaki [terminalia chebula retz.]
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665098/
https://www.ncbi.nlm.nih.gov/pubmed/23723658
http://dx.doi.org/10.4103/0974-8520.108866
work_keys_str_mv AT jirankalgikaryogeshm acomparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz
AT ashokbk acomparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz
AT dwivedirambabur acomparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz
AT jirankalgikaryogeshm comparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz
AT ashokbk comparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz
AT dwivedirambabur comparativeevaluationofintestinaltransittimeoftwodosageformsofharitakiterminaliachebularetz